Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyoko Yoshida

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Clinical and Translational Radiation Oncology|March 20, 2023
Circulating neutrophils and tumor-associated myeloid cells function as a powerful biomarker for response to chemoradiation in locally advanced cervical cancerOlsi Gjyshi, Adam Grippin, Lauren Andring, et al.
Microorganisms|April 28, 2023
Cervicovaginal Microbiota Profiles in Precancerous Lesions and Cervical Cancer among Ethiopian WomenBrhanu Teka, Kyoko Yoshida-Court, Ededia Firdawoke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2024
Human Papilloma Virus Circulating Cell-Free DNA Kinetics in Patients with Cervical Cancer Undergoing Definitive ChemoradiationAaron Seo, Weihong Xiao, Olsi Gjyshi, et al.
Plos One|January 6, 2023
Immune environment and antigen specificity of the T cell receptor repertoire of malignant ascites in ovarian cancerKyoko Yoshida-Court, Tatiana V Karpinets, Aparna Mitra, et al.
Plos One|November 22, 2024
Correction: Immune environment and antigen specificity of the T cell receptor repertoire of malignant ascites in ovarian cancerKyoko Yoshida-Court, Tatiana V Karpinets, Aparna Mitra, et al.
JCO Global Oncology|December 23, 2025
Linking Microbiome Diversity and Immune Profiles in Ethiopian Patients With Cervical CancerKyoko Yoshida-Court, Brhanu Teka, Tatiana Cisneros Napravnik, et al.
Brachytherapy|August 15, 2025
Iterative intraoperative 3T MRI (iMRI)-guided brachytherapy: A prospective study on enhancing implantation precision and dosimetric gains in advanced gynecologic cancersShrikiriti S Rajan, Matthew S Ning, Megan Jacobson, et al.
International Journal of Radiation Oncology, Biology, Physics|January 29, 2020
Microbial Diversity and Composition Is Associated with Patient-Reported Toxicity during Chemoradiation Therapy for Cervical CancerAparna Mitra, Greyson Willis Grossman Biegert, Andrea Y Delgado, et al.
Brachytherapy|December 21, 2023
Exploratory analysis of the cervix tumoral HPV antigen-specific T-cell repertoire during chemoradiation and after brachytherapyGohar S Manzar, Molly B El Alam, Erica J Lynn, et al.
Plos One|March 4, 2021
A prospective study of the adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancersMolly B El Alam, Travis T Sims, Ramez Kouzy, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Clinical and Translational Radiation Oncology|March 20, 2023
Circulating neutrophils and tumor-associated myeloid cells function as a powerful biomarker for response to chemoradiation in locally advanced cervical cancerOlsi Gjyshi, Adam Grippin, Lauren Andring, et al.
Microorganisms|April 28, 2023
Cervicovaginal Microbiota Profiles in Precancerous Lesions and Cervical Cancer among Ethiopian WomenBrhanu Teka, Kyoko Yoshida-Court, Ededia Firdawoke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2024
Human Papilloma Virus Circulating Cell-Free DNA Kinetics in Patients with Cervical Cancer Undergoing Definitive ChemoradiationAaron Seo, Weihong Xiao, Olsi Gjyshi, et al.
Plos One|January 6, 2023
Immune environment and antigen specificity of the T cell receptor repertoire of malignant ascites in ovarian cancerKyoko Yoshida-Court, Tatiana V Karpinets, Aparna Mitra, et al.
Plos One|November 22, 2024
Correction: Immune environment and antigen specificity of the T cell receptor repertoire of malignant ascites in ovarian cancerKyoko Yoshida-Court, Tatiana V Karpinets, Aparna Mitra, et al.
JCO Global Oncology|December 23, 2025
Linking Microbiome Diversity and Immune Profiles in Ethiopian Patients With Cervical CancerKyoko Yoshida-Court, Brhanu Teka, Tatiana Cisneros Napravnik, et al.
Brachytherapy|August 15, 2025
Iterative intraoperative 3T MRI (iMRI)-guided brachytherapy: A prospective study on enhancing implantation precision and dosimetric gains in advanced gynecologic cancersShrikiriti S Rajan, Matthew S Ning, Megan Jacobson, et al.
International Journal of Radiation Oncology, Biology, Physics|January 29, 2020
Microbial Diversity and Composition Is Associated with Patient-Reported Toxicity during Chemoradiation Therapy for Cervical CancerAparna Mitra, Greyson Willis Grossman Biegert, Andrea Y Delgado, et al.
Brachytherapy|December 21, 2023
Exploratory analysis of the cervix tumoral HPV antigen-specific T-cell repertoire during chemoradiation and after brachytherapyGohar S Manzar, Molly B El Alam, Erica J Lynn, et al.
Plos One|March 4, 2021
A prospective study of the adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancersMolly B El Alam, Travis T Sims, Ramez Kouzy, et al.
Pageof 8